Heron Therapeutics(DE:AXD2)
€0.29-0.03 (-8.83%)
DE:AXD2
Heron Therapeutics earnings date
€0.29
At close:-0.03 (-8.83%)
Heron Therapeutics (AXD2) Q4 2024 Earnings Report
4 Followers
DE:AXD2 Q4 2024 EPS Results
- Actual EPS
- EUR 0.02
- Consensus EPS
- -EUR 0.03
- Beat/Miss
- Beat by +EUR 0.05
- One Year Ago EPS
- -EUR 0.06
DE:AXD2 Q4 2024 Revenue Results
- Actual Revenue
- EUR 36.51M
- Expected Revenue
- EUR 33.39M
- Beat/Miss
- Beat by +EUR 3.13M
- YoY Revenue Growth
- +19.13%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/27/2025
- Time
- Before Open
- Conference Call
- Thursday, February 27, 2025
DE:AXD2 Upcoming Earnings
Heron Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
DE:AXD2 Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AXD2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.03- | -0.02 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.02-0.03 | -0.09 | 70.00% (+0.06) | |
| Aug 10, 2026 | 2026 (Q2) | -0.00-0.03 | -0.02 | -50.00% (-0.01) | |
| May 11, 2026 | 2026 (Q1) | -0.02-0.04 | 0.01 | -500.00% (-0.04) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.02 | 0.02 | -200.00% (-0.04) | |
| Nov 04, 2025 | 2025 (Q3) | -0.01-0.09 | -0.03 | -233.33% (-0.06) | |
| Aug 08, 2025 | 2025 (Q2) | -0.01-0.02 | -0.05 | 66.67% (+0.04) | |
| May 06, 2025 | 2025 (Q1) | -0.010.01 | -0.02 | 150.00% (+0.03) | |
| Feb 27, 2025 | 2024 (Q4) | -0.030.02 | -0.06 | 128.57% (+0.08) | |
| Nov 12, 2024 | 2024 (Q3) | -0.03-0.03 | -0.15 | 82.35% (+0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
